Allurion Technologies, Inc. Operating Income
Allurion Technologies, Inc. (ALUR) reported Operating Income of -$3.73 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-05-15
- Allurion Technologies, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$3.73M.
- Allurion Technologies, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$6.29M.
- Allurion Technologies, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$9.63M.
- Allurion Technologies, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$6.95M.
- Allurion Technologies, Inc. operating income (loss) for fiscal 2025 was -$30.16M.
- Allurion Technologies, Inc. operating income (loss) for fiscal 2024 was -$50.20M.
- Allurion Technologies, Inc. operating income (loss) for fiscal 2023 was -$79.08M.
- Allurion Technologies, Inc. operating income (loss) for fiscal 2022 was -$32.01M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$3.73M 10-Q · filed 2026-05-15 | -$10.03M derived: sum of 2 quarters · filed 2026-05-15 | -$19.66M derived: sum of 3 quarters · filed 2026-05-15 | -$26.61M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$15.92M derived: sum of 2 quarters · filed 2026-03-30 | -$22.88M derived: sum of 3 quarters · filed 2026-03-30 | -$30.16M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$9.63M 10-Q · filed 2025-11-17 | -$16.58M derived: sum of 2 quarters · filed 2025-11-17 | -$23.86M 10-Q · filed 2025-11-17 | -$40.98M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$6.95M 10-Q · filed 2025-08-19 | -$14.23M 10-Q · filed 2025-08-19 | -$31.35M derived: sum of 3 quarters · filed 2026-05-15 | -$43.69M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$7.28M 10-Q · filed 2026-05-15 | -$24.40M derived: sum of 2 quarters · filed 2026-05-15 | -$36.74M derived: sum of 3 quarters · filed 2026-05-15 | -$46.08M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$17.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$29.46M derived: sum of 2 quarters · filed 2026-03-30 | -$38.80M derived: sum of 3 quarters · filed 2026-03-30 | -$50.20M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$12.34M 10-Q · filed 2025-11-17 | -$21.69M derived: sum of 2 quarters · filed 2025-11-17 | -$33.08M 10-Q · filed 2025-11-17 | -$58.81M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$9.35M 10-Q/A · filed 2025-08-28 | -$20.74M 10-Q/A · filed 2025-08-28 | -$46.47M derived: sum of 3 quarters · filed 2025-08-28 | -$72.63M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$11.39M 10-Q/A · filed 2025-08-28 | -$37.13M derived: sum of 2 quarters · filed 2025-08-28 | -$63.28M derived: sum of 3 quarters · filed 2025-08-28 | -$76.58M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | -$25.74M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$51.89M derived: sum of 2 quarters · filed 2025-08-28 | -$65.19M derived: sum of 3 quarters · filed 2025-08-28 | -$79.08M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | -$26.15M 10-Q/A · filed 2025-08-28 | -$39.45M derived: sum of 2 quarters · filed 2025-08-28 | -$53.34M 10-Q/A · filed 2025-08-28 | -$63.49M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | -$13.29M 10-Q/A · filed 2025-08-28 | -$27.18M 10-Q/A · filed 2025-08-28 | -$37.33M derived: sum of 3 quarters · filed 2025-08-28 | -$49.32M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | -$13.89M 10-Q/A · filed 2025-08-28 | -$24.04M derived: sum of 2 quarters · filed 2025-08-28 | -$36.02M derived: sum of 3 quarters · filed 2025-08-28 | -$40.32M derived: sum of 4 quarters · filed 2025-08-28 |
| 2022-12-31 | -$10.15M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | -$22.13M derived: sum of 2 quarters · filed 2025-08-28 | -$26.43M derived: sum of 3 quarters · filed 2025-08-28 | -$32.01M 10-K/A · filed 2025-08-28 |
| 2022-09-30 | -$11.98M 10-Q · filed 2023-11-14 | -$16.28M derived: sum of 2 quarters · filed 2023-11-14 | -$21.86M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$4.29M 10-Q · filed 2023-10-20 | -$9.88M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |